Marina Maher Communications (MMC) announced the hire of Joshua Wu, PhD., as Senior Vice President, Performance Analytics.

Temps are falling and so is investor cash as BioSpace reviewed which biotech companies are scooping up the dollars.

Ashfield Engage, part of UDG Healthcare, announced the acquisition of Medaxis, a patient engagement services partner for the life sciences industry that provides services to healthcare professionals and patients.

Evoke, a leading global health and wellness agency, announced the integration with San Francisco-based Evoke Giant to build a seamless North American client partner. The integration formally merges the two agencies while retaining the ability to service clients independently across the United States.

Led by new CEO Dr. Yvonne Greenstreet, Alnylam Pharmaceuticals has a stated ambition to transition the RNA interference therapeutics trailblazer to a top 5 biotech – measured by market capitalization – within the next five years.

Hal Barron, who guided the reinvigoration of the pharmaceutical direction at GlaxoSmithKline, is departing the company as GSK undergoes a planned demerger later during 2022.

Leading market research patient recruitment firm Rare Patient Voice LLC announced another first-quarter 2022 round of promotions and changes to staff, following an initial round earlier in January.

Evoke announced three key leadership hires to the global health and wellness agency’s executive team.

imre named Anna Kotis as the new president of imre Health, as the digital powerhouse continues to elevate its life sciences offerings and catalyze year-over-year growth into more robust digital AOR engagements.

M Booth Health named Stacey Bernstein its new CEO on the heels of the global health communications consultancy’s strongest performing year marked by double-digit growth and multi-million dollar account wins. Bernstein replaces Tim Bird as he transitions into a consultative role.